questionText: To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential merits of age-based eligibility criteria for the respiratory syncytial virus vaccine.
answerText: In June 2023, the Joint Committee on Vaccination and Immunisation (JCVI) suggested an initial respiratory syncytial virus (RSV) programme to potentially vaccinate a cohort aged from 75 to 79 years old, and then for those turning 75 years old in subsequent...
heading: Respiratory Syncytial Virus: Vaccination